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Abstract
Background—Although disturbed flow is thought to play a central role in the development of 
advanced coronary atherosclerotic plaques, no causal relationship has been established. We 
evaluated whether inducing disturbed flow would cause the development of advanced coronary 
plaques, including thin cap fibroatheroma (TCFA).
Methods and Results—D374Y-PCSK9 hypercholesterolemic minipigs (N=5) were instrumented 
with an intracoronary shear-modifying stent (SMS).  Frequency-domain optical coherence 
tomography was obtained at baseline, immediately post-stent, 19, and 34 weeks and used to 
compute shear stress metrics of disturbed flow. At 34 weeks, plaque type was assessed within 
serially-collected histological sections and co-registered to the distribution of each shear metric. 
The SMS caused a flow-limiting stenosis and blood flow exiting the SMS caused regions of 
increased shear stress on the outer curvature and large regions of low and multidirectional shear 
stress on the inner curvature of the vessel. As a result, plaque burden was ~3-fold higher 
downstream of the SMS compared to both upstream of the SMS and in the control artery 
(p<0.001). Advanced plaques were also primarily observed downstream of the SMS, in locations 
initially exposed to both low (p<0.002) and multidirectional (p<0.002) shear stress. TCFA 
regions demonstrated significantly lower shear stress that persisted over the duration of the study 
compared to other plaque types (p<0.005).  
Conclusions—These data support a causal role for lowered and multidirectional shear stress in 
the initiation of advanced coronary atherosclerotic plaques. Persistently lowered shear stress 
appears to be the principal flow disturbance needed for the formation of TCFA. 
 
Key words: atherogenesis, shear stress, thin cap fibroatheroma, optical coherence tomography 
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Introduction 
Coronary heart disease (CHD) is projected to remain the worldwide leading cause of death until 
20301. CHD is a major cause of morbidity and reduced quality of life with enormous economic 
consequences2, 3. Atherosclerosis, a multifocal lipid-driven inflammatory process, is the principal 
underlying pathology in patients with CHD, which commonly presents clinically with symptoms 
secondary to luminal narrowing of an epicardial coronary artery or an acute coronary syndrome 
(ACS). The latter is a major cause of CHD death and most commonly results from rupture at the 
site of a thin cap fibroatheroma (TCFA) leading to coronary thrombosis4.  
The precise environmental cues that lead plaques towards an advanced and high risk 
phenotype are not yet fully elucidated, but disturbed blood flow is thought to play a central role 
in both lesion initiation and progression5. Disturbed flow is most frequently quantified by metrics 
of shear stress, which is the frictional force imposed by blood flowing over the endothelial 
surface, and association between these metrics and coronary atherosclerotic lesion stage have 
been demonstrated in vivo in both animal models6-9 and patients10, 11. However, few studies have 
investigated the impact of prevalent shear conditions on longitudinal development of advanced 
coronary plaques, wherein they report discrepant results. Previous experimental studies6-8, 12 have 
reported TCFA development in arterial segments with persistently low time-averaged wall shear 
stress (WSS) in diabetic hypercholesterolemic pigs. By contrast, clinical studies11 suggested that 
regions of high WSS were associated with development of features of plaque vulnerability. This 
work also showed an association between low WSS and regional plaque progression, consistent 
with the findings of the PREDICTION trial10. While informative, these important studies do not 
confirm a causal role for metrics of disturbed WSS in inducing the formation and progression of 
advanced coronary plaques.  
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In the current study, we hypothesized that: (i) inducing disturbed blood flow initiates 
development of advanced coronary plaque types, including TCFA, and (ii) different longitudinal 
patterns of low, multidirectional, and high WSS metrics determine plaque morphology. To test 
these hypotheses, we developed a stenotic shear modifying stent (SMS)13 that could be placed 
percutaneously to induce regions of persistent blood flow perturbations within the coronary 
arteries of D374Y-PCSK9 hypercholesterolemic transgenic minipigs14. Our results provide 
evidence for a causal role of disturbed flow in the development of advanced coronary plaques 
and extend our previous work demonstrating that inducing disturbed blood flow in a carotid 
artery of hypercholesterolemic mice15, 16 causes the development of TCFA-like plaques.  
 
Methods
Detailed methods are available in the online supplement and the study protocol is summarised in 
Supplemental Figure 1. All animal experiments were performed in accordance with the ethical 
and welfare regulations of the University of Aarhus and approved by the Danish Animal 
Experiments Inspectorate. Briefly, SMS were implanted into either the left anterior descending 
(LAD) or left circumflex (LCx) arteries of hypercholesterolemic D374Y PCSK9 transgenic 
minipigs (N=6), with the unstented artery serving as a control14. Serial intracoronary frequency 
domain optical coherence tomography (FD-OCT) and Doppler flow velocity measurements were 
obtained at 0 (baseline), 0+ (immediately post-stent), 19, and 34 weeks. From these data, the 3-D 
geometry of each artery was reconstructed and computational fluid dynamics (CFD) was 
performed to compute established and custom WSS metrics of disturbed flow. To correlate 
computed WSS metrics to plaque morphology, vessel segments were excised proximal and distal 
to the SMS in the instrumented artery and in a comparable region of the uninstrumented control 
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artery at the final study time point. The segments were serially sectioned and alternating sections 
were stained with hematoxylin and eosin (H&E), picrosirius red (collagen), and muramidase 
(pan macrophage). Stained histological sections from each pig were imaged, contoured 
manually, and accurately co-registered to the corresponding segments of the in vivo 3-D 
reconstructed arteries of that pig over all time points, to evaluate on a local basis (3.6° 
circumferentially and ~105 m axially) the time-course of change in magnitude of each WSS 
metric within each plaque type. Plaques were independently classified by expert 
histopathologists, who were blinded to CFD results, as TCFA, fibrous cap atheroma (FCA), 
pathological intimal thickening (PIT), xanthoma (XA), intimal thickening (IT), or normal vessel 
wall (NOR). A color coding system was used to segment plaque type continuously around the 
circumference of each H&E-stained section (Supplemental Figure 2). The primary readout was 
the mean of each WSS metric within each of the plaque types identified in each histological 
section, averaged over all sections containing that plaque type across all pigs. The accuracy of 
this workflow was confirmed in a formal error analysis (see Supplemental Methods).  
Statistical Analysis 
Variables (stenosis area, blood velocity and total cholesterol) are reported as mean±SD. Some 
variables (WSS metrics of disturbed flow and metrics of plaque size) were log-transformed and 
reported as geometric mean with 95% confidence interval (GM [95% CI]). All statistical 
analyses were performed using a linear mixed-effects model to compare continuous dependent 
variables and various independent categorical variables, including: plaque type or group (fixed 
effect), time (fixed effect), and subject (random effect due to repeated measures of multiple 
histological sections within each pig). Comparisons between normally distributed variables are 
expressed as an arithmetic mean difference with 95% confidence interval (AMD [95%CI]) and 
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log-transformed distributed variables are expressed as a geometric mean ratio with 95% 
confidence interval (GMR [95%CI]). Both outputs come directly from the mixed model with an 
associated p-value. All p-values generated from the linear mixed-effect model and reported in the 
manuscript have been systematically Bonferroni corrected by multiplying each p-value by the 
appropriate number of comparisons. Statistical significance was based on these corrected p-
values being less than 0.05. All statistical analyses were performed in Stata version 13 
(StataCorp, College Station, TX, USA). 
 
Results
One pig died due to acute stent thrombosis immediately after SMS implantation. Of the 
remaining 5 pigs, 4 animals completed the entire study protocol, with one animal dying after 
developing stent thrombosis following completion of intracoronary imaging at the 19 week time 
point. A total of 5957 FD-OCT frames were contoured manually to allow reconstruction and 
CFD modelling for calculation of WSS in 38 vessels comprised of both instrumented and control 
arteries over all time points in 5 pigs. Histology sections were co-registered to the corresponding 
3-D reconstructed arteries. Local plaque type was manually segmented in H&E stained sections 
(N=538). Regional overlaps between these histological measures and WSS metrics of disturbed 
flow were quantified. 
SMS induced atherogenesis and advanced plaque development 
We observed accelerated atherosclerosis resulting from SMS placement. Compared to control 
regions, the segment downstream of the SMS had moderately increased external elastic lamina 
(EEL) area (GM 2.1 [2.0, 2.2] mm2 vs 1.4 [1.3, 1.5] mm2 and GMR 1.6 [1.4, 1.8]; p<0.001) and 
large increases in plaque area (GM 1.3 [1.1, 1.5] mm2 vs 0.2 [0.2, 0.3] mm2 and GMR 6.0 [4.7, 
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8.0]; p<0.001). The segment upstream of the SMS had similar increases in EEL area (GM 2.1 
[1.9, 2.3] mm2 vs 1.4 [1.3, 1.5] mm2 and GMR 1.5 [1.3, 1.7]; p<0.001) but plaque area only 
increased modestly (GM 0.3 [0.3, 0.4] mm2 vs 0.2 [0.2, 0.3] mm2 and GMR 1.5 [1.1, 2.0]; 
p=0.012), which was significantly less than in the downstream segment (GMR 4.0 [3.3, 5.0] in 
downstream versus upstream plaque area; p<0.001). Strikingly, plaque burden was ~3-fold 
higher in the segment downstream of the SMS compared to both the SMS upstream (GMR 3.4 
[2.9, 4.1]; p<0.001) and control artery segments (GMR 3.5 [2.8, 4.4]; p<0.001; Figure 1A).   
Sections from the segment downstream of the SMS exhibited plaques at varying stages of 
advancement (Figure 1B), including NOR (34%), IT (20%), XA (17%), PIT (22%), FCA (4%) 
and TCFA (3%). FCA and TCFA lesions contained a large necrotic core, macrophage 
infiltration, and a fibrous cap (?65 μm for TCFA) with newly deposited collagen, similar to 
human lesions (Figure 1B). The following plaque types developed in the region upstream of the 
SMS: NOR (36%), IT (29%), XA (10%), PIT (20%), and FCA (5%). No TCFA was observed. 
Sections from segments of the uninstrumented artery exhibited NOR (41%), IT (30%), XA (5%), 
and PIT (24%), but no FCA or TCFA were observed (Supplemental Figure 3). 
SMS implantation caused persistent wall shear stress perturbations 
The arithmetic mean initial maximum areal stenosis created by the SMS was 62.6±7.0% (N=5). 
There was a progressive increase in stenosis severity to 83.9±3.1% at 34 weeks (AMD 20.9 
[14.5, 27.4] at 34 weeks versus immediately post-SMS; p<0.001) due to neo-intimal hyperplasia 
within the SMS (Figure 2A, 2B). The stenosis resulted in a reduction of mean blood velocity at 
the inlet of the instrumented vessel from 147.8±41.0 at baseline to 90.7±19.2 mm/s at 34 weeks 
(AMD -57.1 [-93.7, -20.3] mm/s at 34 weeks versus baseline; p=0.018). The change in blood 
velocity in the control vessel over time was not statistically significant (p=0.55; Figure 2C). The 
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reduced blood velocity caused a concomitant reduction in WSS in the instrumented vessel 
(Figure 2D). Notably, in the region downstream of the SMS, the accelerated blood flow exiting 
the SMS was directed towards the outer curvature of the vessel in a concentrated stream, causing 
regions of markedly increased flow localized to the outer curvature. This high kinetic energy in 
the concentrated stream induced flow separation and vortex formation, causing large regions 
with low and multidirectional flow on the inner curvature (Figure 2E). WSS metrics with the 
largest positive change from baseline values over time were the low shear index (LSI), indicating 
regions with lowered WSS; high shear index (HSI), indicating regions with increased WSS; and 
a variant of the transverse wall shear stress (tSS; Figure 2D), indicating multidirectional flow. 
We therefore focused on these metrics for the remainder of the study.
Advanced plaques were initiated by low and multidirectional wall shear stress  
After observing that placement of the SMS increased LSI, HSI, and tSS, we next evaluated 
whether any of these metrics of disturbed flow preferentially co-localized to regions of particular 
plaque types immediately after SMS implantation (t=0+) to explore the initiating stimulus for 
those plaques. Plaques were initially grouped as advanced lesions (TCFA, FCA, and PIT), early 
lesions (XA and IT), or normal vessel wall (NOR) in the segments upstream and downstream of 
the SMS, as well as the uninstrumented control artery of all pigs. In all histological sections, we 
quantified the geometric mean of each WSS metric within each plaque group at t=0+ (Figure 3). 
LSI within advanced lesions located in the downstream segment (N=125 sections) was 
significantly higher compared to those in the upstream (GMR 29.3 [20.7, 41.6]; N=86; p<0.002) 
and control segments (GMR 17.9 [10.9, 29.3]; N=33; p<0.002). LSI, which is a measure that 
increases in value as WSS reduces, was also significantly greater in advanced compared to early 
lesions (GMR 5.5 [4.1, 7.3]; p<0.002) and normal vessel wall (GMR 6.9 [5.2, 9.1]; p<0.002) in 
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the instrumented downstream segment (Figure 3A). By comparison HSI, which is a measure that 
increases in value as WSS increases, exhibited a reverse pattern in the downstream segment with 
reduced values in advanced lesions (except FCA at 19 weeks, see below) that were significantly 
lower compared to early lesions (GMR 0.62 [0.51, 0.76]; p<0.002) and normal vessel (GMR 
0.46 [0.38, 0.56]; p<0.002; Figure 3B). Similar to LSI in the downstream segment, tSS had 
larger values in advanced lesions compared to both early lesions (GMR 1.7 [1.5, 1.9]; p<0.002) 
and normal vessel (GMR 1.8 [1.6, 2.0]; p<0.002). Overall, the striking co-localization of 
advanced lesions to regions of lowered WSS (LSI) and multidirectional WSS (tSS) within the 
downstream segment, where plaque burden was ~3-fold higher compared to other regions, 
suggests that both patterns of disturbed flow contributed to their initiation.  
The time course and magnitude of disturbed wall shear stress determined final plaque type 
Next, we determined whether each plaque type experienced a different time course of disturbed 
flow in the segment downstream of the SMS (Figure 4). TCFA, FCA, and PIT were observed in 
2/5, 3/5 and 5/5 animals, respectively. Over all post-instrumentation times, TCFA regions 
demonstrated higher LSI values (Figure 5A) compared to FCA (GMR 1.8 [1.3, 2.5]; p<0.005) 
and PIT (GMR 1.4 [1.1, 1.9]; p=0.25), although only the comparison with FCA was statistically 
significant. LSI in TCFA was also significantly higher compared to XA (GMR 1.94 [1.47, 2.56], 
p<0.005), IT (GMR 2.75 [2.10, 3.58]; p<0.005), and normal vessel wall (GMR 2.66 [2.05, 3.46]; 
p<0.005). In addition, LSI values were of greater magnitude in PIT compared with values in XA 
(GMR 1.4 [1.2, 1.6]; p<0.005), IT (GMR 1.9 [1.7, 2.2]; p<0.005), and normal vessel wall (GMR 
1.9 [1.7, 2.1]; p<0.005). LSI was also higher in FCA compared to IT (GMR 1.5 [1.2, 1.9]; 
p<0.005) and normal wall (GMR 1.5 [1.2, 1.9]; p<0.005), but not XA (1.1 [0.9, 1.4]; p=0.90). 
Interestingly, FCA was also the only advanced plaque with increased HSI (Figure 5B), wherein 
DOI: 10.1161/CIRCULATIONAHA.115.016270 
10
at 19 weeks FCA was increased compared to PIT (GMR 3.2 [1.8, 5.6]; p<0.005) and TCFA 
(GMR 2.5 [0.9, 5.6]; p=0.79), although the latter comparison was not significant. Finally, 
analysis of tSS (Figure 5C) over all post-instrumentation times was not statistically higher 
between any of the advanced plaque types and only TCFA and PIT showed any statistically 
higher values of tSS, when compared to IT (GMR 1.4 [1.2, 1.7] and 1.3 [1.1, 1.4], respectively; 
p<0.005) and normal vessel wall (GMR 1.4 [1.2, 1.7] and 1.3 [1.2, 1.4], respectively; p<0.005; 
Figure 5C). 
 
Discussion
Previous studies have reported the association between naturally-occurring disturbed blood flow 
and the development of atherosclerotic lesions6-11. These investigations have supported the 
hypothesis that persistent, low WSS may initiate and progress the development of high risk 
plaque features, but do not prove its causal role. In the current study, we imposed a persistent 
perturbation of local WSS by implantation of a SMS. The main findings of our study were, first, 
that SMS implantation induced a heterogeneous pattern of flow disturbance that caused 
accelerated atherogenesis and formation of advanced plaque types in the coronary arteries of 
D374Y-PCSK9 hypercholesterolemic minipigs. Second, we observed that the majority of 
advanced plaques were located in the segment downstream of the SMS (Figure 1) within regions 
of initially lowered WSS (quantified by LSI) and also multidirectional WSS (quantified by tSS; 
Figure 3). In contrast, the upstream SMS and control artery segments exhibited little overlap 
between WSS metrics of disturbed flow and any plaque type (Supplemental Figure 4). Third, 
we observed that compared to other advanced plaque types, TCFA developed in those locations 
downstream of the SMS exposed to the largest and most persistent reduction in WSS over the 
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duration of the study (Figure 5A), consistent with previous observations8. Finally, FCA 
developed in locations subjected to greater degrees of high WSS (quantified by HSI), particularly 
at 19 weeks (Figure 5B), which supports the hypothesis that high WSS may promote a stable 
plaque phenotype. Collectively, these findings demonstrate a causal role for disturbed flow in the 
formation of advanced plaques, including TCFA, within coronary arteries. 
Building on initial studies that suggested a pro-atherogenic role for low and oscillatory 
WSS17, 18, we previously reported that placing a constrictive, external cuff to perturb blood flow 
in the carotid artery of Apo-E knockout mice led to the formation of TCFA upstream and a stable 
plaque downstream of this device. This approach provided the first evidence for a causal role of 
disturbed blood flow in vulnerable and stable plaque formation16. However, their small size and 
different cardiovascular physiology imposes limitations on the study of atherosclerosis 
progression and predilection sites as it relates to man. Furthermore, Reynolds and Dean numbers 
scale with size and are significantly lower in rodent models as compared with values in man19. 
Recent data also suggest limitations of murine models for studying acute inflammatory disease 
processes20. We were therefore motivated to overcome these limitations by studying the coronary 
arteries of a transgenic hyperlipidemic pig model which, in contrast to murine models, develops 
human-like advanced plaques14. Our results are consistent with previous observations that 
lowering WSS induces TCFA15, 16. We now demonstrate that in addition to co-localization with 
regions of   early atherosclerotic lesion formation21, multidirectional WSS may act 
synergistically with lowered WSS to initiate development of advanced coronary plaques 
including TCFA, which has not been reported previously. In addition, our observations that early 
exposure to raised WSS, quantified by HSI, significantly overlapped with formation of early 
plaque types (Figure 3B) and that exposure to high WSS was associated with the development 
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of FCA (Figure 5B), supports further investigation of the hypothesis that high WSS may be 
protective by inducing formation of stable plaque phenotypes.  
The marked variation in plaque type observed in both the axial and circumferential 
directions of each instrumented vessel (Figure 4) motivated our novel approach to determine 
how temporal changes in WSS may influence final plaque morphology on a local, high-
resolution scale. This type of analysis is important as plaque rupture is likely determined by 
variations in the biomechanical properties, and possibly endothelial cell mechanobiology, on this 
scale22. This approach was enabled by using FD-OCT rather than intravascular ultrasound 
(IVUS) for 3-D reconstruction of the vessel lumen and its curvature. We performed a detailed 
error propagation analysis that confirmed an error of less than 10% for computed WSS despite 
using a commercial FD-OCT system that could not provide ECG-gated acquisitions. In addition, 
we performed a detailed error analysis of the 3-D histology approach developed for co-
registering WSS metrics from CFD to histological data, which demonstrated a circumferential 
error of 265 μm and axial error of 340 μm that represents a significant improvement to previous 
reports from both others6-8, 12, 23, 24 and ourselves25-29. Importantly, this 3-D histology error 
analysis included assessment of the reproducibility of identification of the same vessel segment 
of interest from the FD-OCT images through time. Therefore, it accounts for small changes in 
vessel size that may occur over time due to remodelling or acquisition of the FD-OCT at 
different average positions within the cardiac cycle (see Supplemental Methods). 
Our data show that development of advanced lesions in the SMS treated artery directly 
resulted from induced changes in local blood flow. Two new metrics were developed to quantify 
those changes relative to the instrumented vessel at baseline (i.e., before SMS placement) over a 
continuous range, namely the LSI and HSI. These metrics require no a priori assumption of a 
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threshold value of WSS for determining non-normal WSS magnitudes and are applicable to the 
study of animals of different sizes and humans. This approach may facilitate evaluation of 
changes in WSS over time by overcoming potential issues arising from using a global threshold 
for defining low and high WSS, as previously reported in the literature6-8, 23, 30-32. Interestingly, 
the geometric mean of the absolute values of WSS within regions of LSI was 0.7 [0.6, 0.8] Pa 
(Supplemental Figure 5), which is lower than the binary threshold values of 1 to 1.2 Pa reported 
previously6-8, 23, 30-32. 
The finding that low and multidirectional flow accelerated the initiation and development 
of all advanced plaque types is consistent with previous experimental data demonstrating that 
such flow disturbances promote a pro-atherogenic endothelial cell type, which is characterized 
by: increased expression of pro-inflammatory adhesion molecules33, 34, impaired nitric oxide 
production35, increased production of reactive oxygen species, augmented permeability to LDL36 
and enhanced attraction and adhesion of monocytes. Furthermore, studies in hyperlipidemic 
mice37, rabbits38, pigs12, and humans10 consistently demonstrate that atherosclerotic lesions 
preferentially occur in regions with natural low and multidirectional WSS conditions, including 
curved vessel segments and bifurcations39. 
We studied D374Y-PCSK9 transgenic hypercholesterolemic Yucatan minipigs which 
have growth curves that suit long term serial invasive follow-up studies and exhibit chronically 
elevated cholesterol when fed a cholate-free high fat high cholesterol diet (HFHC), resulting 
from a gain of function mutation in the proprotein convertase subtilisin/kexin type 9 gene 
resulting in impaired LDL cholesterol clearance. When fed the HFHC diet used in this study, 
these animals typically achieve a total cholesterol of ~20 mmol/L (~773 mg/dl) and LDL 
cholesterol of ~11 mmol/L (~425 mg/dl)14, which is similar to the cholesterol levels of animals 
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in the current study (Supplemental Figure 6).  
Study limitations 
Several limitations of this study should be considered. First, a small cohort of 5 pigs were studied 
and human-like fibroatheromata developed in only 3/5 animals, including TCFA in 2/5 animals. 
Even with this sample size, the high-resolution analysis provided sufficient power to allow 
identification of statistically significant associations between WSS metrics and final plaque 
morphology. However, further studies in a larger cohort are needed to provide sufficient sample 
size to assess the relative magnitude, sensitivity, and specificity of LSI, HSI, and tSS, or their 
combination, for precise prediction of the development of each advanced plaque type. Second, 
the temporal evolution of WSS metrics could be related to plaque morphology only at the final 
time point, when the animals were euthanized for histology. Further work is needed to evaluate 
the time course of development of each advanced plaque. Extending the duration of follow-up 
and HFHC diet with further histological evaluation of the proximal portion of the coronary 
arteries is also needed to enable more detailed comparison of the determinants of advanced 
plaque development in the uninstrumented and SMS-treated arteries. Our results suggest the 
utility of this model for longitudinal studies of the development of advanced human-like plaques, 
including TCFA, especially as advanced plaques develop at a predictable location within the 
coronary artery tree in a practical timeframe. Finally, in the current study, we principally 
considered the effect of induced local flow disturbance through placement of the SMS. While 
this intervention may induce an altered arterial remodeling response compared to that induced by 
naturally-occurring flow disturbances, we suggest that this approach enables direct testing of the 
causal role of different patterns of flow disturbances on advanced coronary atherosclerotic lesion 
development and thus complements natural history studies. 
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Conclusions
We have established a novel model of accelerated atherogenesis and formation of advanced 
human-like atherosclerotic plaques, including TCFA. This model combined with FD-OCT 
derived CFD and 3-D histology provides a new means of studying the biomechanics and 
mechanobiology of human-like advanced coronary plaques. Our results demonstrate a causal role 
for lowered and multidirectional WSS within the coronaries as determinants of final plaque type. 
Persistently lowered WSS appears to be the principal hemodynamic disturbance needed for the 
formation of TCFA. Further investigation to specify the relative contributions of persistently 
decreased, increased, and altered multidirectional shear stress on the development of each of the 
different advanced coronary atherosclerotic plaque types is warranted.  
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Figure Legends: 
Figure 1. (A) Box and whisker plot of plaque burden computed as plaque (or intima) area 
divided by media area for each histological section and scaled by an assumed normal intima-
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media areal ratio of 0.225 (linear ratio is 0.3). Plaque burden was ~3-fold higher downstream of 
the SMS compared to the SMS upstream and control artery segments (***p<0.001). Red dots 
indicate outliers. (B) Representative histological sections of advanced plaque types in the vessel 
segment downstream of the SMS. Advanced lesions were identified based on the presence of a 
necrotic core, inflammation (i.e., accumulation of macrophages), and presence of a fibrous cap. 
TCFA was defined when fibrous cap thickness was ?65 μm (white arrow indicates TCFA cap in 
10x picrosirius red image, which is further magnified to 40x in the entire bottom row of images). 
The white box in each 2x image indicates region of 10x image.  
 
Figure 2. (A) Representative FD-OCT images of the maximum stenosis within the implanted 
SMS at 0 (baseline), 0+ (immediately post-SMS), 19, and 34 weeks showing increased severity 
of the stenosis due to intimal hyperplasia. (B) Maximum areal stenosis (%) averaged over all 
pigs, which increased from 0+ to 34 weeks (***p<0.001). (C) Mean inlet blood velocity (m/s) 
decreased in the instrumented artery over time (*p<0.02 compared to baseline), whereas the 
contralateral control artery did not significantly change. (D) Box and whisker plot of the relative 
change from baseline of 8 WSS metrics (see Supplemental Methods for list and definitions) in 
the instrumented downstream segment, computed as the difference of each metric from baseline 
over all pigs and all post-SMS implant time points and then scaled by the maximum median of 
all metrics (WSS). The parameters in which SMS implant caused the greatest positive change 
were LSI, HSI, and tSS. (E) Blood velocity and streamlines from CFD in the instrumented and 
contralateral control arteries of one representative pig. The instrumented vessel exhibits high 
flow on the outer and low and multidirectional flow on the inner curvature, whereas the control 
artery maintains a normal and nearly homogeneous flow profile. At select axial locations in each 
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vessel, cross-sections are provided to show the distribution of velocity. In the bar plots (B and 
C), data are expressed as mean±SD. 
 
Figure 3. LSI, HSI, and tSS grouped by plaque type (advanced – TCFA, FCA, and PIT; early – 
IT and XA, and normal wall) within each of the vessel segments at immediately post-SMS 
implantation (time=0+) and scaled by the maximum value of the 3 metrics (LSI). (A) Of all WSS 
metrics, LSI had the highest relative magnitude within advanced lesions in the instrumented 
downstream segment, which was statistically higher than LSI within advanced lesions of other 
vessel segments (**p<0.002) and other plaque groups in the downstream segment (**p<0.002). 
(B) HSI was nearly exclusively present in the instrumented downstream segment.  Interestingly, 
maximal values within this segment were lowest in advanced lesions compared to early lesions 
(**p<0.002) and normal wall (**p<0.002). (C) tSS was similar to LSI with highest values in 
regions of advanced lesions within the instrumented downstream segment that were statistically 
different from those in other segments (**p<0.002) and different from early lesions (**p<0.002) 
and normal wall (**p<0.002) in the downstream segment. *Indicates statistically higher values 
of the given WSS metric within the plaque group designated by the bar over which it is placed 
versus the same plaque group in other vessel segments (control – ?, instrumented upstream – ?, 
and instrumented downstream – ?) and different plaque groups within the same segment 
(advanced – ?, early – ?, and normal – ?). Data are expressed as geometric mean plus upper 
limit of 95%CI. 
 
Figure 4. (Top row) Representative 3-D reconstruction of LSI within one pig over time (location 
of SMS indicated by grey lines). (Remaining rows) Panels are obtained by computationally 
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isolating the downstream segment (indicated by the black box in the 3-D representation), 
opening the vessel and laying it flat (“en-face” with the endothelium facing up) to demonstrate 
the patterns of LSI, tSS, and plaque type. LSI and tSS are scaled from 0 (null value, indicated by 
blue) to 1 (maximum value, indicated by red). Plaque type is displayed as a function of plaque 
burden, ranging from normal wall given by the flesh-color to the maximum plaque burden given 
by the highest color intensity of each plaque type (TCFA – red, FCA – green, PIT – blue, XA – 
violet, and IT – yellow). The histological data are obtained at the end time point (34 weeks) and 
then co-registered to the vessel reconstructions at each time point (see Supplemental Methods).  
 
Figure 5. LSI, HSI, and tSS within each plaque type of the instrumented downstream segment, 
averaged over all sections containing that plaque type and all pigs at each time point. These shear 
metric values are scaled by the maximum over all shear metrics (LSI at 19 weeks) to facilitate 
comparisons. (A) Over all post-SMS implant times as a whole, LSI had a higher presence in 
regions of TCFA compared to FCA (p<0.005) and PIT (p=0.25), though the latter was not 
significant, and all advanced lesions exhibited a higher LSI compared to early lesions and normal 
vessel (p<0.005, except FCA versus XA where p=0.90). (B) HSI in the advanced lesions was 
generally lower than other plaque groups, except regions of FCA at 18 weeks (p<0.005) 
suggesting that this stimulus may have promoted the stable plaque phenotype. (C) tSS initially 
exhibited a statistically higher presence in regions of advanced plaques compared to early lesions 
and normal vessel (p<0.005) at immediately post-SMS implant, but it was not consistent over 
time. *Indicates statistically higher values of the given WSS metric within the advanced plaque 
type designated by the bar over which it is placed versus other plaque types (TCFA – ?, FCA – 
?, PIT – ?, XA – ?, IT – ?, and NOR – ?). Data are expressed as geometric mean plus upper limit 
of 95%CI. 
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SUPPLEMENTAL MATERIAL 
 
Supplemental Methods 
 
Animals 
All animal experiments were performed in accordance with the ethical and welfare 
regulations of the University of Aarhus and approved by the Danish Animal Experiments 
Inspectorate. The study protocol is shown in Supplemental Figure 1. Six female D3749 
PCSK9 transgenic minipigs on a Yucatan background were fed a cholate free high fat high 
cholesterol (HFHC) diet consisting of 20% lard and 2% cholesterol (Sigma-Aldrich, UK) 
added to a standard pig diet of 68.0% barley, 15.0% oat, 9.6% soy bean meal, 2.0% animal 
fat 3.0% molasses, and 2.4% minerals and vitamins. Each pig received 700-900g HFHC diet 
divided into two portions daily for 1-4 months prior to instrumentation
1
. During the study, the 
weight of the animals increased from 48 ± 2 kg (mean +/- SD) at baseline to 75 ± 2 kg at the 
end of the protocol (34 weeks).  
The day before each catheterization procedure, pigs were fasted overnight with access 
to drinking water ad libitum. On the day of each procedure, pigs were pre-medicated with a 
weight-adjusted mixture of 0.5 mg/kg of midazolam (Accord Healthcare, Gothenburg, 
Sweden) and 4 mg/kg of azaperone (Janssen Animal Health, Beerse, Belgium) before 
anesthesia induction using 0.5 mg/kg of intravenous etomidate (Hypnomidate, Janssen-Cilag, 
UK). Following endotracheal intubation, the pigs were mechanically ventilated with 60% 
oxygen in pressure regulated volume-controlled mode (S/5 Avance, Datex-Ohmeda, GE 
Healthcare, UK). Anesthesia was maintained with Sevoflurane (Abbvie A/S, Denmark), to a 
mean alveolar concentration (MAC) of 1.2 to 1.4%, together with continuous intravenous 
infusion of fentanyl 0.02 mg/kg/hr (Hameln Pharmaceuticals, Germany). During the 
procedure, continuous monitoring of electrocardiogram, oxygen saturations, end-tidal CO2 
and arterial blood pressure was performed. At the time of all interventional procedures, the 
2 
 
pigs received 1g of intravenous ampicillin (PharmaCoDane, Herlev, Denmark) before and 
after the catheterization procedures. 
 
Shear-modifying stent implantation and follow-up cardiac catheterization procedures 
One week prior to implant of a stenotic shear modifying stent (SMS)
2
, all pigs 
received 300 mg aspirin (Takeda Pharma, Roskilde, Denmark) daily. 300 mg of clopidogrel 
(Actavis Group, Hafnarfjördur, Iceland) was administered 24 hours beforehand. To minimize 
peri-procedural arrhythmia, the animals were pre-treated with 25 mg atenolol (Takeda 
Pharma) once daily and 200 mg amiodarone (Sandoz, Copenhagen, Denmark) twice daily for 
one week pre- and post-procedure. After SMS implantation, all pigs received 75 mg of 
aspirin and 75 mg of clopidogrel once daily for the remainder of the study. 
An 8F arterial sheath (Arrow International, Reading, PA, USA) was placed 
percutaneously under ultrasound guidance. Unfractionated heparin 5000u (LEO Pharma, 
Ballerup, Denmark) was administered intravenously and supplemented with a further 1000u 
each hour. The left coronary artery was engaged with an 8F Hockey Stick I guiding catheter. 
All angiographic acquisitions were performed with ventilation briefly paused during image 
acquisition to minimise respiratory motion artefacts and after administration of intracoronary 
isosorbide dinitrate (0.3-1.0 mg). Coronary angiograms were acquired in orthogonal views 
during injection of iodinated contrast (iohexol 140mgI/mL, GE healthcare, Oslo, Norway) 
using a clinical grade digital fluoroscopy suite (Allura Xper FD10, Philips, Eindhoven, The 
Netherlands). Coronary flow velocity was measured in the left anterior descending (LAD) 
and left circumflex (LCx) coronary arteries using a ComboWire (Volcano Corporation, San 
Diego, CA, USA). The ComboWire was advanced to the tip of the guide catheter, where 
aortic pressure and ComboWire pressures were equalized and then advanced into a proximal 
vessel segment at least 5 mm away from any major angiographic side branch (>2 mm 
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diameter) to measure the inlet velocity over 10 to 20 stable cardiac cycles. Intracoronary 
frequency domain optical coherence tomography (FD-OCT) was performed in both the LAD 
and LCx using the Illumien system and Dragonfly imaging catheters (St Jude, St. Paul, MN, 
USA). Prior to each pullback, the FD-OCT catheter was imaged in orthogonal views during 
injection of iodinated contrast to enable 3-D reconstruction of the catheter path within the 
artery. FD-OCT pullbacks at a speed of 20 mm/s were performed during pump injection of 
iohexol (4-8 mL/s). After completion of baseline measurements, a SMS was implanted in the 
LAD (N=1) and LCx (N=5). Coronary angiography, coronary flow velocity and FD-OCT 
measurements were repeated in the stented vessel. The non-stented artery served as a control. 
Follow-up cardiac catheterization procedures and acquisition of coronary angiograms, 
coronary flow velocity and FD-OCT data in both the stented and control arteries were 
performed as above at 19 and 34 weeks after initial stent implantation. 
 
Tissue preparation and histology 
After the final catheterization procedure, a median sternotomy was performed under 
general anaesthesia and the heart exposed. Unfractionated heparin (10,000u) was injected 
intravenously followed by injection of 50 mL saturated potassium chloride solution (KPBS) 
into the ascending aorta under direct vision. The heart was excised and the coronary arteries 
flushed with KPBS. Next, the coronary arteries were perfusion-fixed at 100 mmHg for 1 
hour, followed by immersion fixation for 24 hours in 4% formaldehyde diluted in PBS 
(VWR, Prolabo, Belgium), after which the heart was stored in PBS at 5
o
C until further 
processing.  
Before excision, the surface of each artery was marked with indelible Tissue Marking 
Dye (Triangle Biomedical Sciences, Durham, NC, USA) that was visible on histological 
sections, which, together with the attached myocardium, served as circumferential fiducial 
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markers for subsequent co-registration of each histology section to the corresponding location 
on the 3-D artery reconstructed from FD-OCT. 5 mm tissue blocks containing the coronary 
artery and underlying myocardium were cut immediately distal and proximal to the SMS 
edges. In each uninstrumented control artery, a 5 mm tissue block was excised at an axial 
position that was at a comparable distance from the left main bifurcation as the proximal edge 
of the stent in the instrumented vessel. At each step in the histology processing, the coronary 
arteries were photographed with an adjacent reference scale to enable estimation of change in 
arterial length resulting from each individual processing step. 
Sections from each 5 mm tissue block were collected at 3 µm-thick intervals over a 
distance of 2.5 mm in the blocks adjacent to the stent and 1 mm in the control, and stained 
with haematoxylin and eosin (H&E), picrosirius red (collagen), and muramidase (pan 
macrophage marker). For the latter, we used a modified version of the protocol described by 
Falk et al
3
. Briefly, proteolytic antigen retrieval (Dako Cytomation S3007) was performed 
followed by Protein Block (X0909, Dako , USA), both for 10 minutes. The primary antibody 
(Dako, muramidase polyclonal rabbit anti-human antibody, diluted 1:500) was applied for 2 
hours at room temperature. Subsequently, a biotinylated secondary antibody (Dako 
Cytomation Multilink, diluted 1:100) and streptavidin-alkaline phosphatase (Vector 
Laboratories SA-5100, diluted 1:500) was applied for 30 min each. Staining was detected 
with Permanent Red (Dako Cytomation), after which the slides were dehydrated, cleared, and 
cover-slipped. Digitized images of the histology sections were acquired using an Olympus 
BX50 light microscope with a Colorview 2 camera.  
 
3-D artery reconstruction and computational fluid dynamics 
The 3-D geometries of the instrumented and control arteries were obtained by placing 
lumen contours segmented from FD-OCT frames along the path of the catheter during 
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pullback. The catheter path was defined by reconstructing the 3-D shape of the Dragonfly 
catheter from orthogonal angiographic frames using the CASS 5.11 software (Pie Medical, 
Netherlands) and then obtaining the centreline of this reconstruction using the Vascular 
Modelling Toolkit (VMTK, Orbix, UK). Contours of the vessel lumen and plaque 
distributions were segmented from each frame of the FD-OCT pullbacks using a commercial 
imaging workstation (St Jude Medical) and echoPlaque 4.0 (Indec Medical Systems, Santa 
Clara, CA, USA). Only clear image frames with visible lumen and vessel wall for >270
o
 
continuous arc were analyzed. Whenever a side branch was present in an OCT image, the 
lumen was segmented as if no side branch were present. To obtain the final in vivo 3-D 
geometry of the artery from FD-OCT, the catheter path and frame contours (lumen and 
plaque) were loaded into custom software developed in Matlab (Mathworks, Natick, MA, 
USA) that performed three primary functions. First, the location of each frame was 
determined by the speed of the catheter pullback. Second, to place the contours normal to the 
reconstructed catheter centerline and to account for catheter torsion, a discrete approximation 
to the Frenet–Serret formulae4 was employed to identify the relative orientations of each 
contour. Finally, to determine the absolute orientation of each contour, a single rotation angle 
around the catheter centerline was calculated for all contours by using the out-of-centre 
vector approach described by Wahle et al.
4
 For this approach, the FD-OCT reconstruction is 
compared to an angiography reconstruction of the vessel that was obtained using the CASS 
5.11 software (Pie Medical, Maastricht, Netherlands). The points of all contours along the 
catheter path represent the in vivo lumen surface, which was then smoothed in VMTK.  This 
approach enables 3-D reconstruction of the artery in its in vivo conformation from the FD-
OCT data. We validated the approach with a detailed error propagation analysis (see below), 
vessel phantoms, and a pilot pig study
5
.  
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The 3-D reconstruction of the arterial lumen from FD-OCT data was used for 
computational fluid dynamics (CFD) simulations to compute wall shear stress metrics of 
disturbed flow and perform 3-D histology (Supplemental Figure 1). The lumen surface was 
meshed using a combination of ICEM CFD (Ansys, Pittsburgh, PA, USA) and Gambit 
version 2.4.6 (Ansys). The mesh was then imported into the commercial package Fluent 
version 6.3 (Ansys) to numerically solve the Navier-Stokes equations of motion for a fluid. In 
addition to defining the lumen geometry, properties of the fluid and boundary conditions 
were also prescribed within the model. Blood was assumed to be an incompressible 
Newtonian fluid with a viscosity of 3.5 mPas
6
 and density of 1050 kg/m
3
.
7
 Simulations 
imposed a pulsatile flow of the blood at the inlet of the vessel by assigning a plug flow profile 
equal to the peak velocity measured at each point in the cardiac cycle.
8
 The corresponding 
velocity wave form represented the average wave form over all cardiac cycles acquired with 
the ComboWire. The inlet was also extended to allow the flow to become fully developed 
before entering into the actual lumen reconstruction. The outlet of the vessel had a prescribed 
pressure of 0 mmHg. The lumen surface was assumed to be stationary with a no-slip 
boundary condition.  
The primary output of the CFD simulations was a wall shear stress vector at each 
point on the lumen surface and at each point in the cardiac cycle (broken into 20 time steps 
for the simulation), which were then imported into a custom Matlab program to quantify 
metrics of local hemodynamics (primarily disturbed flow), including: time-averaged wall 
shear stress (WSS)
9
, oscillatory shear index (OSI)
10, 11
, relative residence time (RRT)
12
, wall 
shear stress gradient (SG)
9
, wall shear stress angle deviation (SAD)
13
 and the recently 
developed transverse wall shear stress (tSS), which considers the multi-directionality of the 
flow field
14, 15
 (Supplemental Table 1). In addition to these established metrics, we developed 
two new WSS metrics, the low shear index (LSI) and the high shear index (HSI). 
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Development of these metrics was motivated by having data on the shear stress profile of the 
SMS-implanted artery prior to its placement at baseline when the artery has physiological 
flow and is non-atherosclerotic, as well as after SMS implantation, which perturbs flow and 
causes atherogenesis. We reasoned that metrics quantifying regional differences in WSS at 
each post-instrumented time point compared with baseline, may identify the types of flow 
disturbance that are most atherogenic. Although this approach could be used to examine 
longitudinal changes in multiple descriptors of local flow conditions, we initially focused on 
changes in WSS magnitude. LSI quantifies reduction in WSS, with its value increasing as 
WSS reduces. By contrast, HSI is a measure of an increase in WSS, with its value increasing 
as WSS increases.  The thresholds for LSI and HSI were determined by normalizing, via log-
transformation, the baseline WSS values of the instrumented vessel before SMS placement, 
after which the bottom and top 10
th
 percent of the distribution (equal to 1.28*standard 
deviation) were used for each metric, respectively. Exponential transformation of these two 
values was used to obtain the absolute threshold values of WSS for discriminating low and 
high WSS. Values of WSS at each point on the 3-D reconstructed artery after SMS 
implantation were compared to the LSI and HSI threshold values from baseline at each post-
stent time point to characterize the degree of low or high WSS on a continuous scale (for 
example, WSS at points on the vessel lumen below the LSI threshold would have positive 
LSI values, whereas those above the LSI threshold would have LSI values equal to 0). This 
definition of low and high WSS allows for a window of normal shear, thus the absence of one 
metric does not imply the presence of the other. 
 
Analysis to determine shear stress within each plaque type  
To quantify spatial overlaps between WSS metrics and histopathological features of 
atherosclerosis, we co-registered histology information to the reconstructed in vivo lumen 
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from FD-OCT through a multi-step process termed 3-D histology, which we first described in 
previous work in the rabbit aorta
16
. First, 3 m-thick histology sections were serially 
collected over the first 2.5 mm of the block (equivalent to ~4.5 mm in vivo). In control tissue 
blocks, only 1.0 mm was assessed (equivalent to ~1.7 mm in vivo). Sections were 
sequentially microtomed and organized onto 10 alternating slides, each with 2 adjacent 
sections per slide, resulting in an interval between slides of 6 µm to allow evaluation of up to 
10 stains over the length of the segment. This method provided an interval of 60 m between 
sections for a given stain. Plaque type and morphology were classified at 60 m intervals 
according to the Virmani classification by expert histopathologists (authors CBP and EF) 
who were blinded to the CFD and FD-OCT data
17
. Plaques were categorized as thin-cap 
fibroatheroma (TCFA), fibrous cap atheroma (FCA), pathological intimal thickening (PIT), 
xanthoma (XA), intimal thickening (IT), or normal vessel wall (NOR) and a color coding 
system (red for TCFA, green for FCA, blue for PIT, pink for XA, yellow for IT, and black for 
NOR) was used to delineate plaque type on a local (i.e., point-to-point) basis within each 
H&E-stained section (Supplemental Figure 2) using Microsoft Paint (Microsoft, Redmond, 
WA, USA). The analysis was either performed on individual plaque types or plaque types 
grouped as advanced (TCFA, FCA, and PIT), early (defined as XA and IT), or non-
diseased/normal (NOR). Regarding the determination of progressive lesions, PIT was 
classified based on the presence of foam cells, extracellular lipid, and/or calcium depositions. 
FCA was classified based on the presence of a necrotic core containing necrotic cells and the 
absence of collagen, determined from the H&E and picrosirius red stains. Fibrous cap 
thickness was measured on the picrosirius red stain using Image J version 1.46 (NIH, USA) 
and fibroatheromas with a cap thickness less than or equal to 65 m were designated as 
TCFA
17
.  
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On the digitized histology sections, the lumen, internal elastic lamina, and external 
elastic lamina contours for the H&E stain were segmented (Clemex Technologies, Longueuil, 
QC, Canada). A custom Matlab program was developed, based on previous work in our 
group
16, 18, 19
, to discretize contours with the same number of equidistantly spaced, user-
defined nodes circumferentially (100) as were contained in the reconstructed vessel 
(composed of FD-OCT frames). The intima to media ratio was computed at each 
circumferential point of each histology section to quantify plaque burden. Contours were 
circumferentially aligned using the myocardium as a reference and co-registered with the 3-D 
vessel reconstructed from FD-OCT images at the point of maximum inner curvature, as the 
artery courses over the surface of the curved myocardium in vivo. Thus, this approach 
corrects for rotational artefacts and shrinkage about the radial and circumferential directions. 
Co-registration about the axial direction of the vessel (i.e., its long-axis) was based on the 
identification of bifurcations in both histology sections and FD-OCT frames and, in the 
instrumented vessel, the stent, which, together with images of vessel segments taken at each 
stage of tissue processing for histology, allowed computation of a shrinkage factor. The mean 
(±SD) shrinkage factor from the loaded, in vivo vessel to post-processing for histology was 
41±6% and 45±4% in the control and instrumented vessel segments, respectively, which was 
not statistically different (p=0.39). To ensure the same vessel region was always identical 
over time, the length of each in vivo vessel segment at each time was scaled by the ratio of 
the original length at the current time compared to the final time point (34 weeks), based on 
identified anatomical landmarks (i.e., the stent and bifurcations). Using this overall approach, 
the range of FD-OCT frames acquired for a particular vessel segment can be matched to the 
serially-collected histology sections, whose interval is constant over that segment. A linear 
interpolation function in Matlab was used to interpolate plaque burden measures at each point 
of each histology section over the reconstructed vessel segment corresponding to the 
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identified FD-OCT frames. A similar interpolation approach was used for plaque type, 
wherein in-between values of each RGB color vector (indicating plaque type) were rounded 
to the nearest plaque type by computing a “distance” between each possible color vector and 
using the minimum as the nearest color.   
Following this co-registration process, every node in both the reconstructed in vivo 
vessel segment and histological sections contained several metrics: coordinates, WSS metrics 
of disturbed flow, plaque type, and plaque burden. The magnitude of each WSS metric within 
each plaque type was then determined on a local scale. To avoid artificially inflating 
statistical power, each histological section was treated as a separate, repeated measurement 
within each pig. Thus, the mean WSS metric for each plaque type was determined on a per 
histological section basis, which corresponds to 60 µm axial increments within the 
histological block and ~105 µm increments in vivo. Because the axial resolution of FD-OCT 
is 200 µm, we used a linear interpolation function in Matlab to re-discretize the reconstructed 
in vivo vessel segment into a grid with a higher resolution of nodal spacing axially that 
enabled matches with the histological sections. To facilitate comparisons between WSS 
metrics, all metrics were scaled to create a continuous range of severity from 0 (null value) to 
1 (the maximum severity of the type of flow disturbance detected by that metric). WSS, SG, 
and RRT were scaled by the maximum value within each vessel, OSI, LSI, and HSI were 
scaled by the theoretical maximum value (0.5, 100, and 100, respectively), SAD was scaled 
by the number π (assuming that an angle deviation of 180o is the maximum disturbance), and 
tSS was scaled by the WSS at each respective point in the vessel (the theoretical maximum of 
the metric). Because tSS is scaled by a changing factor, the resultant spatial patterns may 
differ from the original metric. Although scaling can be subjective, it is necessary to 
determine the functionality of each WSS metric and it enables construction of a hierarchy of 
the relative contributions of the type of flow disturbance described by each metric, and their 
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combinations, to the development of different atherosclerotic plaque types. Next, a threshold 
of 0.1 was also imposed to de-noise the data, based on the error in computing WSS of 10% 
within our system (see Error Analysis section). Finally, the primary readout was the mean of 
each WSS metric within each of the plaque types identified in each histological section, 
averaged over all sections containing that plaque type across all pigs. The final readout was 
then scaled by the maximum WSS metric value across all metrics analysed to facilitate 
comparisons between metrics.   
 
Error analysis 
To quantify the resolution of our output metrics (e.g., WSS), we performed an error 
analysis on the primary components that make up the workflow of our system, including the 
accuracy of FD-OCT, 3-D histology, and characterizing plaque morphology locally within 
each cross-section.  
FD-OCT has a resolution of 15 µm in-plane and 200 µm axially (referring to the long-
axis of the vessel, which is sometimes also called the longitudinal direction). This results in 
an in-plane error of 0.9% for an average pig vessel radius of 1.75 mm. Because FD-OCT 
cannot be gated, an additional error is introduced due to motion of the vessel over the cardiac 
cycle. The diameter change of the vessel during the cardiac cycle was measured by recording 
an intravascular ultrasound (IVUS) measurement without pulling back for one vessel in one 
pig. We introduced pump injection of iodinated contrast during this IVUS measurement to 
simulate the pressure experienced by the vessel during normal FD-OCT pullback, which 
might attenuate vessel motion over the cardiac cycle. We found fluctuations of 1 mm
2
 around 
an average area of 16.5 mm
2
, which corresponds to an error in the radius of 3%. The overall 
combined error, therefore, in reconstructing vessel radius is 3.1% or 54 µm, which equates to 
an error in WSS of 9.3% (because WSS is dependent on the cube of the radius). As IVUS 
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was used, which has an in-plane resolution of 200 µm, the computed error represents the 
maximum error expected in our FD-OCT based reconstructions. Nevertheless, an error in 
WSS of less than 10% compares favourably with previous reports from both our
16, 18, 19
 and 
other groups
20-24
. 
 Next, the error associated with co-registration of the histology information onto the 
vessel reconstruction was assessed. We computed error as the difference in observations and 
measurements of these steps from the same observer at two time points, 6 months apart and 
in a masked fashion the second time. In the axial direction, error was due to the axial 
increment of obtaining histological sections, identification of matches between FD-OCT 
frames and histology sections, and measurements of the vessel at different stages of 
histological processing. For these three processes, the average error over all instrumented 
vessels was found to be ~105 µm, 280±111 µm and 162±61 µm, respectively, which equates 
to a combined error of 340 µm. Thus, this axial error is within the resolution of 2 FD-OCT 
frames. Circumferentially, the error was due to identification of the myocardium on the 
reconstructed vessel based on qualitative examination of the largest inner curvature. Over all 
reconstructed instrumented vessels at all time points, this error was found to be 11.4±3.6°, 
which is equivalent to an arc length of 265±82 µm.  
 Finally, the error in characterizing plaque morphology was assessed by having the 
same observer re-classify plaque types on 20 sections selected from all vessel locations and 
pigs 3 months after the original classification and in a masked fashion the second time. The 
average error was 8.9% over all sections. Inconsistencies were found only in the 
classification of early lesions (XA and IT) and normal vessel wall (NOR), whereas all 
advanced plaque types were re-classified exactly the same as the original classification.  
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Supplemental Tables 
Supplemental Table 1: Summary of WSS metrics of disturbed flow used in this study and 
the mathematical formulation for each.  
  
Hemodynamic Parameter 
 
Formulation 
Time Averaged Wall 
Shear Stress (WSS) 
    
 
 
     
 
 
   
WSS gradient (SG) SG = 
 
 
   
    
  
 
 
  
    
  
 
 
  
    
  
 
 
  
 
 
 
WSS Angle Deviation (SAD) See Hyun et al.
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Oscillatory Shear Index (OSI)     
 
 
     
       
 
 
 
        
 
 
   
Relative Residence Time 
(RRT) 
    
 
              
 
Low Shear Index (LSI) 
 
     
                      
            
 
 
                                                  
 
High Shear Index (HSI) 
 
     
                      
      
 
 
                                                  
 
Transverse Wall Shear Stress 
(tSS) 
 
     
 
 
           
   
 
 
  
    
 
 
   
   
 
 
   
 
   represents the normal to the arterial surface 
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Supplemental Figures and Figure Legends 
 
Supplemental Figure 1. Workflow of the data acquired during cardiac catheterization and 
downstream analysis. For each vessel at each time point, bi-plane angiography of the FD-
OCT catheter path is performed immediately before pullback. The FD-OCT pullback is 
performed, acquiring image cross-sections over a vessel length of ~50 mm. Finally, blood 
velocity measurements were acquired at the inlet of each vessel using a Combowire. These 
measurements allowed reconstruction of the catheter path and vessel lumen to perform CFD, 
which, in turn, allowed calculation of WSS metrics of disturbed flow. Histological data were 
co-registered to the vessel reconstructions and thus WSS metrics to investigate whether any 
plaque types co-localized with particular flow disturbances. Most of these analysis steps 
employed custom Matlab software developed in-house, as described above.   
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Supplemental Figure 2. Processing steps taken to characterize plaque type from H&E stained 
histology sections and co-register it to the in vivo lumen reconstruction from FD-OCT. (A) 
The reconstructed vessel post-implantation of the stent (shown in grey) and the location from 
which serial sections were acquired downstream of the stent (sections acquired upstream are 
not indicated). (B) Each section is manually segmented and the contour is discretized into a 
user-defined number of nodes by custom software. (C) Colored lines are manually drawn 
around the lumen of each section to indicate plaque type (TCFA – red, FCA – green, PIT – 
blue, XA – violet, IT – yellow, and NOR – black or beige). (D) Custom software is used to 
extract the color from the image and store it within the corresponding nodes of the 
reconstructed lumen contour. (E) The nodes of the histology lumen are co-registered to the 
reconstructed in vivo lumen segment (from which they were derived), which can be isolated 
and laid flat (endothelium upwards) to display the pattern of each plaque type. After co-
registration, each node of the reconstructed lumen (and histology sections) has plaque type 
and all WSS metrics defined.  
16 
 
 
Supplemental Figure 3. Representative images of histological sections stained for 
macrophages (muramidase) and collagen (picrosirius red) in the control and upstream and 
downstream SMS vessel segments, demonstrating larger plaques in the downstream SMS 
segment. 
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Supplemental Figure 4. LSI, HSI, and tSS within each plaque type of the instrumented 
downstream segment, averaged over all sections containing that plaque type and all pigs at 
each time point. All shear values are scaled by the maximum over all shear metrics (LSI at 19 
weeks in the downstream instrumented vessel, seen in Figure 5A) to facilitate comparisons. 
Panels A, B, C show each metric, respectively, in the instrumented upstream segment and 
panels D, E, F similarly show each metric in the control segment. These plots demonstrate a 
relative absence of these metrics of disturbed flow in these vessel segments and, over all 
times as a whole, there were no statistical differences between these metrics in progressive 
lesions versus other plaque types. Individual plaque comparisons at each time point were not 
considered. Data are expressed as geometric mean plus upper limit of 95%CI. 
 
  
18 
 
 
Supplemental Figure 5. (A) Absolute values of WSS averaged over all regions of each plaque 
type. Over all times as a whole, there were no statistical differences between the advanced 
plaque types. TCFA and PIT were statistically different from both IT (p<0.005) and normal 
wall (p<0.005), but FCA was statistically different from normal wall only (p<0.005). This 
finding demonstrates that LSI and HSI better distinguish between plaque types, based on 
magnitude changes of WSS in diseased compared to normal or baseline vessels, compared to 
WSS alone. (B) Absolute values of WSS averaged only within regions of each plaque type 
that contain LSI values greater than zero. Over all times as a whole, TCFA was statistically 
different from FCA (p<0.005), as well as XA (p=0.048) and normal wall (p<0.005). PIT 
exhibited the only other statistical difference, compared to normal wall (p<0.005). The 
geometric mean of these values is 0.7 [0.6, 0.8] Pa, averaged over all plaque types and time 
points (including baseline). This finding demonstrates a potential improvement to previous 
investigators who used a much higher binary threshold (1 – 1.2 Pa) to determine low shear, 
which may not be as specific to regions of plaque development. *Indicates statistically 
different values of WSS within the plaque type designated by the bar over which it is placed 
versus other plaque types (TCFA – α, FCA – β, PIT – γ, XA – δ, IT – ε, and NOR – ζ). Data 
are expressed as geometric mean plus upper limit of 95%CI. 
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Supplemental Figure 6. Total blood cholesterol levels (mmol/L) averaged over all pigs at 
each time point. Compared to baseline, there was a statistically significant increase at 19 
weeks (**p=0.006), which reduced at 34 weeks and was not significantly different from 
baseline (p=0.082). The threshold for abnormally elevated blood cholesterol is ~2 mmol/L 
(~77 mg/dl). Data are expressed as mean±SD. 
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